Solid Biosciences (SLDB) Stock Price
$3.3 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
1 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Solid Biosciences, AI stock picks, stock alerts and much more.
SLDB AI Stock Analysis
AI stock analysis for SLDB is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Solid Biosciences (SLDB) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Solid Biosciences (SLDB) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Solid Biosciences (SLDB), currently trading at $3.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SLDB
-
Solid Biosciences Inc.
-
Symbol
SLDB
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
255.7M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.45 1.1% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.87 2.6% |
2 |
 |
Moderna MRNA |
$27.22 0.6% |
3 |
 |
Anavex Life Sciences AVXL |
$9.42 0.3% |
5 |
 |
BridgeBio Pharma BBIO |
$36.31 1% |
4 |
News
SLDB Alternative Data
Web Traffic
Solid Biosciences receives an estimated 13888 monthly visitors to solidbio.com.
-
Web Traffic
13888
-
Change from Previous Month
3.6%
-
3 Month Change
96.4%
-
YoY Change
96.4%
Twitter Followers
Solid Biosciences has 1,456 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
1456
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.2%
-
YoY Change
2.2%
LinkedIn Followers
11,419 are following Solid Biosciences on LinkedIn, up by 3.2% over the last month.
-
LinkedIn Followers
11419
-
Daily Change
0%
-
1 Month Change
3.2%
-
3 Month Change
14.4%
Job Postings
Solid Biosciences has an estimated 6 open job postings, which is down -45.5% over the last month.
-
Job Postings
6
-
Daily Change
0%
-
1 Month Change
45.5%
-
3 Month Change
50%
-
YoY Change
50%
LinkedIn Employees
According to LinkedIn, Solid Biosciences has 125 employees, up by 1.6% over the last month.
-
LinkedIn Employees
125
-
Daily Change
1.6%
-
1 Month Change
1.6%
-
3 Month Change
3.8%
-
YoY Change
3.8%
News Mentions
Solid Biosciences was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
20%
-
1 Month Change
20%
-
3 Month Change
33.3%
Reddit Mentions
Solid Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Solid Biosciences is 69 out of 100 (bullish).
-
Business Outlook
69
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
SLDB Financials
SLDB Key Metrics
-
Total Revenue
$0
-
Net Income
-$42.6M
-
Earnings per Share
-$1.04
-
Free cash flow
-$29.8M
-
EBITDA
-$42M
-
EBITDA Ratio
0
-
Total Assets
$188.7M
SLDB 2-year Revenue & Income
SLDB 2-year Free Cash Flow
SLDB Technicals
SLDB SMA
SLDB RSI
FAQ
What's the current price of Solid Biosciences (SLDB) Stock?
The price of an Solid Biosciences (SLDB) share is $3.3.
What's the market cap of Solid Biosciences?
The current market cap of Solid Biosciences is 255.7M.
Should I buy or sell SLDB?
Solid Biosciences shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Solid Biosciences is better viewed as a hold or accumulate position while waiting for further developments.
Is Solid Biosciences a good investment?
The current analysis of Solid Biosciences' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Solid Biosciences' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Solid Biosciences (SLDB) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Solid Biosciences stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Solid Biosciences (SLDB) that investors often compare it to?
Solid Biosciences (SLDB) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Solid Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Solid Biosciences' stock price to be around $3.18 in 2026. Starting from the current price of $3.3, this represents a 3.5% change in price, indicating a neutral outlook for the stock.
How to buy Solid Biosciences (SLDB) Stock?
Solid Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Solid Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.